DAFNA Capital Management »

Vigil Neuroscience shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Vigil Neuroscience (VIGL) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Vigil Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Vigil Neuroscience held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vigil Neuroscience by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $245k 72k 3.41
2023-12-31 $243k 72k 3.38
2023-09-30 $929k 172k 5.39
2023-06-30 $1.6M 172k 9.40
2023-03-31 $1.7M 172k 9.79
2022-12-31 $2.1M 169k 12.50
2022-09-30 $2.0M 216k 9.10
2022-06-30 $257k 100k 2.58
2022-03-31 $701k 100k 7.03

More positions owned by DAFNA Capital Management

Stereotaxis Com New (STXS)
Spdr S&p Biotech Etf Etf (XBI)
Revolution Medicines (RVMD)
Cytokinetics Com New (CYTK)
AtriCure (ATRC)
Merus N V (MRUS)
Ishares Nasdaq Biotech Indx Etf (IBB)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Xenon Pharmaceuticals (XENE)
Neurocrine Biosciences (NBIX)
Arcus Biosciences Incorporated (RCUS)
Syndax Pharmaceuticals (SNDX)
Day One Biopharmaceuticals I (DAWN)
Ascendis Pharma A/s Sponsored Adr (ASND)

View all positions for DAFNA Capital Management

Top funds holding Vigil Neuroscience

XTX Topco
Advisor Group Holdings

View all funds holding Vigil Neuroscience